Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elisabeth Kelber is active.

Publication


Featured researches published by Elisabeth Kelber.


Annals of Nutrition and Metabolism | 1997

Bile acid metabolism by colonic bacteria in continuous culture: effects of starch and pH.

Stefan Christl; Hans-Peter Bartram; Paul A; Elisabeth Kelber; Wolfgang Scheppach; Heinrich Kasper

Secondary bile acids (BA) have been shown to be involved as a promoting agent in the adenoma-carcinoma sequence of colorectal cancer. In previous studies, fermentation of starch has been shown to inhibit the degradation of primary to secondary BA by the colonic microflora. This study was designed to investigate BA metabolism in continuous cultures of mixed fecal bacteria to get further insights into the mechanisms of this inhibition. Fermentation vessels were fed with media containing cholic (0.6 g/l) and chenodeoxycholic acid (0.4 g/l). Cultures were either starch-free or enriched with starch (10 g/l). pH was controlled and adjusted to 7.0 or 6.0. Total culture duration was 28 days and concentrations of BA, short-chain fatty acids (SCFA), and starch were measured periodically. At pH 6, significantly more primary BA remained in the media and less secondary BA were produced. Total BA concentrations were lower at pH7. SCFA concentrations were higher in the vessels supplemented with starch. Starch was completely fermented and not present in significant amounts in any fermentation vial after the first week. These data indicate that bacterial breakdown of primary to secondary BA is inhibited when starch is simultaneously fermented. This effect can be explained by the reduction of pH resulting from SCFA production. Considering these findings, resistant starch which escapes assimilation in the small bowel may be a protective factor against colorectal cancer.


Nutrition and Cancer | 1996

Effects of fish oil on fecal bacterial enzymes and steroid excretion in healthy volunteers: implications for colon cancer prevention.

Hans-Peter Bartram; Andrea Gostner; Elisabeth Kelber; Gerda Dusel; Antje Weimer; Wolfgang Scheppach; Heinrich Kasper

Diet-induced changes in fecal excretion of secondary bile acids, certain neutral sterols, and bacterial enzyme activities are known to play a role in colon cancer development. Dietary fish oil (FO) has been implicated as a protective agent in colon carcinogenesis. In the present study, the effects of FO and corn oil (CO) on these fecal parameters were investigated in 24 healthy volunteers consuming a low- or a high-fat diet (30% or 50% of energy derived from fat). After four weeks of FO or CO supplementation (4.4 g of n-3 fatty acids/day), no significant differences were noted for fecal activities of beta-glucuronidase, beta-glucosidase, and sulfatase, nor was fecal bile acid excretion significantly affected by FO or CO consumption. However, daily excretion of the putative colon carcinogen 4-cholesten-3-one was significantly lower in the FO than in the CO period during low- and high-fat experiments. This may be another biochemical mechanism by which FO exerts its protective effect on colon cancer development.


European Journal of Nutrition | 1995

Beeinflussung der fäkalen Gallensäureexkretion durch Fischöl bei gesunden Probanden

H.-P. Bartram; Andrea Gostner; Wolfgang Scheppach; Elisabeth Kelber; Gerda Dusel; Flavio Keller; Heinrich Kasper

ZusammenfassungVerschiedene Studien weisen auf einen protektiven Effekt von Fischöl bei der Kolonkarzinomentstehung hin. Mögliche Einflüsse auf die muscosale Prostaglandin-E2-Synthese wurden hierbei als Wirkungsmechanismus beschrieben. Zusätzliche Effekte auf die fäkale Exkretion von Gallensäuren könnten ebenso von Bedeutung sein, da insbesondere sekundäre Gallensäuren als Promotoren bei der Kolontumorentstehung angesehen werden. In der vorliegenden Studie wurde bei 12 gesunden Probanden der Effekt einer täglichen Supplementierung mit 11 g Fischöl (FO) bzw. Maiskeimöl (MO) über jeweils 4 Wochen zusätzlich zu einer fettreduzierten Basiskost (30 % der Gesamtenergie als Fett) auf die fäkale Exkretion von Gallensäuren untersucht. Die Analyse des fäkalen Gallensäurenspektrums erfolgte gaschromatographisch. Die Gesamtausscheidung an Gallensäuren war unter FO nicht signifikant verschieden von derjenigen unter MO (301,9 vs. 320,3 mg/Tag). Unter FO ergab sich jedoch eine tendenziell niedrigere Exkretion der sekundären Gallensäure Lithocholsäure als unter MO (99,6 vs. 109,4 mg/Tag, p=0,22). Da sekundäre Gallensäuren als ein wesentlicher Promotor der Kolonkarzinogenese angesehen werden, sind diese Veränderungen positiv im Hinblick auf eine mögliche Kolonkarzinomprävention zu werten.SummarySeveral studies indicated a protective effect of fish oil on colon carcionogenesis which might be due to alterations in prostaglandin E2 synthesis of the colonic mucosa. Additional effects on fecal bile acid excretion may also play a role since especially secondary bile acids are known to act as promotors in colon cancer development. In the present study possible influences on bile acid excretion were investigated in 12 healthy volunteers whose daily diet was supplemented for 4 weeks with 11 g of fish oil (FO) and corn oil (CO) per day, respectively. Fecal bile acids were analyzed by gas-liquid-chromatography. Fecal excretion of total bile acids was not different during the periods of FO and CO-supplementation (301.9 vs. 320.3 mg/day). However, a non-significant trend to a lower daily excretion of the secondary bile acid lithocholic acid was found after FO compared to CO-ingestion (99.6 vs. 109.4 mg/day; p=0.22). Since secondary bile acids are known promotors of colon carcinogenesis, these findings may implicate a favorable situation with respect to colon cancer prevention.Several studies indicated a protective effect of fish oil on colon carcinogenesis which might be due to alterations in prostaglandin E2 synthesis of the colonic mucosa. Additional effects on fecal bile acid excretion may also play a role since especially secondary bile acids are known to act as promoters in colon cancer development. In the present study possible influences on bile acid excretion were investigated in 12 healthy volunteers whose daily diet was supplemented for 4 weeks with 11 g of fish oil (FO) and corn oil (CO) per day, respectively. Fecal bile acids were analyzed by gas-liquid-chromatography. Fecal excretion of total bile acids was not different during the periods of FO and CO-supplementation (301.9 vs. 320.3 mg/day). However, a non-significant trend to a lower daily excretion of the secondary bile acid lithocholic acid was found after FO compared to CO-ingestion (99.6 vs. 109.4 mg/day; p = 0.22). Since secondary bile acids are known promoters of colon carcinogenesis, these findings may implicate a favorable situation with respect to colon cancer prevention.


The American Journal of Clinical Nutrition | 1994

Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in health subjects

Hans-Peter Bartram; Wolfgang Scheppach; Stephanie Gerlach; Gotthard Ruckdeschel; Elisabeth Kelber; Heinrich Kasper


European Journal of Nutrition | 1998

Effect of dietary fish oil on fecal bile acid and neutral sterol excretion in healthy volunteers.

H.-P. Bartram; Andrea Gostner; Elisabeth Kelber; Gerda Dusel; Wolfgang Scheppach; Heinrich Kasper


European Journal of Nutrition | 1995

Effects of fish oil on fecal bile acid excretion in healthy volunteers

H. Peter Bartram; Andrea Gostner; Wolfgang Scheppach; Elisabeth Kelber; Gerda Dusel; Flavio Keller; Heinrich Kasper


Gastroenterology | 2001

Lack of carotenoid effects on cell proliferation and expression of cell cycle regulating factors in human colon carcinoma cells

Hardi Luehrs; Juergen Schauber; Kerstin Backhaus; Elisabeth Kelber; Ralph Melcher; Wolfgang Scheppach; Thomas P. Menzel


Gastroenterology | 2000

Additive effects of a butyrate/TNF-a combination on adoptosis in colorectal carcinoma cells

Theo Kudlich; Hardi Luehrs; Frank Boxberger; Florian Kreth; Gerda Dusel; Elisabeth Kelber; Ralph Melcher; Wolgang Scheppach; Thomas P. Menzel


Gastroenterology | 2000

Synergistic effects of aspirin and butyrate on induction of p21CIP1/WAF1 expression

Florian Kreth; Hardi Luehrs; Theo Kudlich; Juergen Schauber; Elisabeth Kelber; Kerstin Krott; Wolfgang Scheppach; Thomas Menzel


Gastroenterology | 2000

Hyperacetylation of non-histone protein HMG17 in butyrate treated human colon adenocarcinoma cells

Hardi Luehrs; Robert Hock; Juergen Schauber; Kerstin Krott; Elisabeth Kelber; Wolfgang Scheppach; Thomas P. Menzel

Collaboration


Dive into the Elisabeth Kelber's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gerda Dusel

University of Würzburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hardi Luehrs

University of Würzburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Antje Weimer

University of Würzburg

View shared research outputs
Top Co-Authors

Avatar

Frank Boxberger

University of Erlangen-Nuremberg

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge